A Genome Screen of Families with Multiple Cases of Prostate Cancer: Evidence of Genetic Heterogeneity-Reference-Cited by-同舟云学术

A Genome Screen of Families with Multiple Cases of Prostate Cancer: Evidence of Genetic Heterogeneity

Published:2001-07 Issue:1 Volume:69 Page:148-158
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Hsieh Chih-lin,Oakley-Girvan Ingrid,Balise Raymond R.,Halpern Jerry,Gallagher Richard P.,Wu Anna H.,Kolonel Laurence N.,O'Brien Laura E.,Lin Iping G.,Van Den Berg David J.,Teh Chong-Ze,West Dee W.,Whittemore Alice S.

Publisher

Elsevier BV

Subject

Genetics(clinical),Genetics

Reference65 articles.

1. Highly complex chromosomal aberrations in bone marrow of a patient with metastatic prostate neoplasm;Azar;Cancer Genet Cytogenet,1997

2. Evidence for a prostate cancer-susceptibility locus on chromosome 20;Berry;Am J Hum Genet,2000

3. Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer;Berry;Am J Hum Genet,2000

4. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43;Berthon;Am J Hum Genet,1998

5. Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer;Bock;Am J Hum Genet,2001

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer genotyping for risk stratification and precision treatment;Current Urology;2024-01-06

2. Identification of a novel recurrent EEF2 gene amplification in familial prostate tumors;Genes, Chromosomes and Cancer;2022-12-23

3. LncRNApolymorphisms and urologic cancer risk;Environmental and Molecular Mutagenesis;2022-03-02

4. Long Non-Coding RNAs at the Chromosomal Risk Loci Identified by Prostate and Breast Cancer GWAS;Genes;2021-12-20

5. CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer;Clinical Cancer Research;2020-01-22